Loading stock data…
LMRI
$10.00+0.43 (+4.49%)
Market ClosedLast close May 1
Lumexa Imaging Holdings, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.00
Potential Upside
5%
Whystock Fair Value$10.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomog...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$896.71M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-8.04%
Volume
Today's trading volume
431,493
Recent News
Lumexa Imaging Q4 Earnings Call Highlights
Lumexa Imaging (NASDAQ:LMRI) reported fourth-quarter and full-year 2025 results that management said exceeded its preliminary earnings announcement, marking the company’s first earnings call as a public company following its IPO. Executives highlighted revenue growth, expanding adjusted EBITDA margi
Lumexa: Q4 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 5 cents per share. The diagnostic imaging chain posted revenue of $1.02 billion in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $262.7 million.
Is Lumexa Imaging Holdings (LMRI) Pricing Look Misaligned After Recent Imaging Sector Attention
If you are wondering whether Lumexa Imaging Holdings is attractively priced or already reflects its potential, this article walks through key numbers so you can judge the value for yourself. The share price closed at US$14.45, with a 30-day return of 33.8%, a 7-day return showing a 6.6% decline, and a year-to-date return showing a 17.7% decline, which has caught the attention of investors watching for shifts in sentiment. Recent coverage around Lumexa has focused on its position in the...
Raymond James Upgrades Lumexa Imaging Holdings, Inc. (LMRI) to Strong Buy with an Unchanged $23 Price Target
Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) is among the 11 Newly-Listed NASDAQ Stocks to Buy Now. On February 9, 2026, Raymond James upgraded Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) to Strong Buy from Outperform with an unchanged $23 price target. Raymond James cited valuation following the recent selloff, noting that Lumexa trades at a six-times EBITDA discount […]
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback
Why Lumexa Imaging Holdings (LMRI) Is On Investors’ Radar Today Lumexa Imaging Holdings (LMRI) has attracted attention after recent share price moves, with the stock down 2.9% over the past week and 16% over the past month, prompting closer scrutiny of its fundamentals. See our latest analysis for Lumexa Imaging Holdings. At a share price of $15.56, Lumexa Imaging Holdings is coming off a weak patch, with a 7 day share price return of 10.06% and a 30 day share price return of 15.98%. This...